Form 4: Quest Diagnostics SVP Patrick Plewman Reports Stock Transactions
SEC Form 4 Filing
Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, reports the acquisition and disposal of company stock.
Summary
- Patrick Plewman, a Senior Vice President at Quest Diagnostics, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On January 29, 2025, Plewman acquired 57 shares of common stock at a price of $158.036 per share through a dividend reinvestment plan.
- Plewman also disposed of an unspecified amount of shares.
- Following these transactions, Plewman beneficially owns 16,345 shares of Quest Diagnostics stock, which includes exempt purchases made under the company's stock purchase plan since the date of the last filing on Form 4.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive, which is a routine occurrence.
Positives
- The acquisition of shares through a dividend reinvestment plan indicates confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential impact on market sentiment.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of stock transaction (acquisition and disposal). |
| 01/31/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.